Pre-clinical studies have demonstrated a possible correlation between obesity-induced hormones (leptin and IGF-1) and PDAC chemoresistance via augmented epithelial-to-mesenchymal transformation (EMT). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.